Results 221 to 230 of about 58,766 (263)
Some of the next articles are maybe not open access.
Current Treatment Options in Oncology, 2001
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +2 more sources
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +2 more sources
Surgical Clinics of North America, 2002
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +2 more sources
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +2 more sources
Management of malignant pleural effusions
Advances in Therapy, 2010Malignant pleural effusions are a common clinical problem in patients with primary thoracic malignancy and metastatic malignancy to the thorax. Symptoms can be debilitating and can impair tolerance of anticancer therapy. This article presents a comprehensive review of pharmaceutical and nonpharmaceutical approaches to the management of malignant ...
Uzbeck, Mateen H +6 more
openaire +3 more sources
Annals of Internal Medicine, 1978
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +2 more sources
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +2 more sources
Fatigue and malignant pleural effusions
BMJ Supportive & Palliative Care, 2021Dear Editors We completely agree with Twose et al 1 that until now the primary focus in both clinical practice and trials has been on interventions in malignant pleural effusions (MPEs), tailored to mitigating breathlessness and preventing admissions, with little consideration of other factors potentially of greater priority to the patient.
Avinash Aujayeb, Donna Wakefield
openaire +2 more sources
Management of Malignant Pleural Effusions
Chest, 1993Malignant pleural effusions (MPEs) are a common complication of advanced malignancies, particularly lung and breast cancer. They are caused by a variety of mechanisms including tumor obstruction of lymphatic flow, spread of malignant cells via the systemic circulation, and tumor invasion of the pulmonary arterioles.
openaire +2 more sources
Management of malignant pleural effusion
Journal of Surgical Oncology, 1978AbstractA pleural effusion is a frequent complication of malignant disease. Essential to the care of oncology patients is a fundamental knowledge of the pathophysiology and treatment of such effusions. This article discusses the current thoughts concerning the occurrence of malignant effusions, outlines the current available methods and agents employed
D W, Greenwald +2 more
openaire +2 more sources
Annali italiani di chirurgia, 2007
Malignant pleural effusion is a frequent condition with important prognostic repercussions on duration and quality of life. The neoplasms that more frequently determine pleural effusion are lung and breast cancer and pleural mesothelioma. Lymphomas, tumours of the genitourinary tract and gastrointestinal tract as a group account for a further 25 ...
Cusumano G. +10 more
openaire +2 more sources
Malignant pleural effusion is a frequent condition with important prognostic repercussions on duration and quality of life. The neoplasms that more frequently determine pleural effusion are lung and breast cancer and pleural mesothelioma. Lymphomas, tumours of the genitourinary tract and gastrointestinal tract as a group account for a further 25 ...
Cusumano G. +10 more
openaire +2 more sources
Phenotyping malignant pleural effusions
Current Opinion in Pulmonary Medicine, 2016Patients with malignant pleural effusions (MPEs) are heterogenous in their disease course, symptom severity, responses to cancer therapies, fluid recurrence rates, and thus need for definitive fluid control measures. To tailor the most appropriate treatment for individual patients, clinicians need to 'phenotype' the patients and predict their clinical ...
Macy M S, Lui +2 more
openaire +2 more sources
Sonography of malignant pleural effusion
European Radiology, 1997Two hundred and ten patients with exudative pleural effusion were studied by ultrasound for sonographic signs of pleural carcinomatosis. Images were evaluated for echoes within the fluid, septations, sheet-like or nodular pleural masses, and associated lesions of the lung. Our results showed that sonographic findings of echogenic or septated fluid were
C, Görg, I, Restrepo, W B, Schwerk
openaire +2 more sources